Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Votes that count - potential in the short term

"The infringer's conclusions will likely be influenced by what other infringers do."

It seems that is already the case. Now, with this "win" under their belt infringers should be scrambling.

Is investor concern a case of over analysis?  As a peripheral investor, it looks like things couldn't be better. 

Has one named infringer to date not settled with favorable results to ptsc?

 

Share
New Message
Please login to post a reply